Search Press releases

19 Mar 2021

UCB Gains CE Mark for ava Connect[®], a first-in-class electromechanical device for use with biologic treatment in rheumatology and dermatology

Read More
12 Mar 2021

Acquisitions of own shares and disposals of own shares

Read More
5 Mar 2021

Share Repurchase Program 2021 to cover UCB's Long Term Incentive Plans for its employees

Read More
5 Mar 2021

Disposals of own shares

Read More
26 Feb 2021

Disposals of own shares

Read More
25 Feb 2021

UCB - sustaining growth, now and into the future

Read More

Stay up-to-date on the latest news and information from UCB